Sigilon Therapeutics, Inc. SGTX
22.47 +22.47
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 12.94M | 9.60M | 13.37M | 14.15M | 4.64M | |
| 12.94M | 9.60M | 13.37M | 14.15M | 4.64M | |
| -43.67M | -75.64M | -52.64M | -44.12M | -23.07M | |
| -43.56M | -77.31M | -54.61M | -43.92M | -22.77M | |
| -17.42 | -31.59 | -98.15 | -139.62 | -119.47 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 43.35M | 108.51M | 203.42M | 76.64M | 64.69M | |
| 87.28M | 144.37M | 225.05M | 90.38M | 67.67M | |
| 48.14M | 67.21M | 78.89M | 77.93M | 66.69M | |
| 28.06M | 33.50M | 37.06M | 25.05M | 4.96M | |
| 39.14M | 77.16M | 146.16M | -77.76M | -36.10M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -51.47M | -78.41M | -61.65M | -50.07M | 38.33M | |
| -12.08M | -18.06M | -972.00K | -1.21M | -1.65M | |
| -1.61M | 1.55M | 189.40M | 63.24M | 24.23M | |
| -307.00K | -1.83M | -972.00K | -1.21M | -1.65M | |
| -65.16M | -94.91M | 126.78M | 11.96M | 60.91M |